Variant report
Variant | esv3523758 |
---|---|
Chromosome Location | chr4:120013745-120014177 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:120013479..120014990-chr4:120129629..120131701,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17331353 | chr4:120013791-120013792 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs11729297 | chr4:120013809-120013810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139646935 | chr4:120013810-120013811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs71595355 | chr4:120013813-120013814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2014993 | chr4:120013824-120013825 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11943321 | chr4:120013827-120013828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34175584 | chr4:120013837-120013838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76664398 | chr4:120013838-120013839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530024358 | chr4:120013847-120013848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569722857 | chr4:120013850-120013851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372099356 | chr4:120013851-120013852 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541901805 | chr4:120013854-120013855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185359549 | chr4:120013887-120013888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531034183 | chr4:120013901-120013902 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188790808 | chr4:120013913-120013914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543381144 | chr4:120013927-120013928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563496259 | chr4:120013952-120013953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181542097 | chr4:120013970-120013971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552433911 | chr4:120013982-120013983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565876233 | chr4:120013983-120013984 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186417516 | chr4:120014012-120014013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552535474 | chr4:120014015-120014016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547881798 | chr4:120014082-120014083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567776676 | chr4:120014083-120014084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190823643 | chr4:120014118-120014119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556665744 | chr4:120014121-120014122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs72908559 | chr4:120014133-120014134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566259422 | chr4:120014171-120014172 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144278683 | chr4:120014173-120014174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:120003400-120014200 | Weak transcription | Left Ventricle | heart |
2 | chr4:120003400-120014400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr4:120003600-120014600 | Weak transcription | Right Atrium | heart |
4 | chr4:120009000-120017600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr4:120009200-120014200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr4:120009200-120014200 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
7 | chr4:120009200-120019000 | Weak transcription | Fetal Intestine Large | intestine |
8 | chr4:120009400-120014400 | Weak transcription | NHEK | skin |
9 | chr4:120009400-120014600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr4:120013000-120015400 | Enhancers | Stomach Mucosa | stomach |
11 | chr4:120013200-120014400 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
12 | chr4:120013200-120015200 | Enhancers | HepG2 | liver |
13 | chr4:120013400-120014600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr4:120013600-120014000 | Weak transcription | Pancreas | Pancrea |
15 | chr4:120013600-120014200 | Weak transcription | A549 | lung |
16 | chr4:120014000-120015000 | Enhancers | Pancreas | Pancrea |